Bormio Nunes Julia H., Hager Sonja, Mathuber Marlene, Pósa Vivien, Roller Alexander, Enyedy Éva Anna, . . . Kowol Christian R. (2020). Cancer Cell Resistance Against the Clinically Investigated Thiosemicarbazone COTI-2 Is Based on Formation of Intracellular Copper Complex Glutathione Adducts and ABCC1-Mediated Efflux.
Chicago Style (17th ed.) CitationBormio Nunes Julia H., et al. Cancer Cell Resistance Against the Clinically Investigated Thiosemicarbazone COTI-2 Is Based on Formation of Intracellular Copper Complex Glutathione Adducts and ABCC1-Mediated Efflux. 2020.
MLA idézésBormio Nunes Julia H., et al. Cancer Cell Resistance Against the Clinically Investigated Thiosemicarbazone COTI-2 Is Based on Formation of Intracellular Copper Complex Glutathione Adducts and ABCC1-Mediated Efflux. 2020.